VPS39 anticorps (C-Term)
Aperçu rapide pour VPS39 anticorps (C-Term) (ABIN783395)
Antigène
Voir toutes VPS39 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- This antibody detects VPS39 / VAM6 at C-term. At least four isoforms of VPS39 are known to exist, this antibody will detect all four. VPS39 antibody is predicted not to cross-react with TRAP1.
-
Réactivité croisée (Details)
- Species reactivity (tested):Human, mouse, rat
-
Purification
- Affinity chromatography purified via peptide column
-
Immunogène
- 18 amino acid peptide near the carboxy terminus of human VPS39
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS containing 0.02 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2 - 8 °C for up to three months or (in aliquots) at -20 °C for longer.
-
-
- VPS39 (Vacuolar Protein Sorting 39 Homolog (VPS39))
-
Autre désignation
- VPS39
-
Sujet
- VPS39 is the mammalian homolog of the yeast vacuolar protein VAM6, that in mammals, promotes lysosome clustering and fusion in vivo. VPS39 is also thought to modulate the TGF-b response by coupling the TGF-b receptor complex to the Smad pathway. Similar to the related protein TRAP1, the VPS39 protein is essential for early embryonic development, with mice lacking VPS39 dying at or before E6.5.Synonyms: KIAA0770, VAM6, Vam6/Vps39-like protein
-
ID gène
- 23339
-
NCBI Accession
- NP_056104
-
UniProt
- Q96JC1
-
Pathways
- SARS-CoV-2 Protein Interactome
Antigène
-